These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
489 related articles for article (PubMed ID: 27680307)
1. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment. Liu C; Zhang X; Song Y; Wang Y; Zhang F; Zhang Y; Zhang Y; Lan X Atherosclerosis; 2016 Nov; 254():263-270. PubMed ID: 27680307 [TBL] [Abstract][Full Text] [Related]
2. Detection of atherosclerotic plaques in ApoE-deficient mice using (99m)Tc-duramycin. Liu Z; Larsen BT; Lerman LO; Gray BD; Barber C; Hedayat AF; Zhao M; Furenlid LR; Pak KY; Woolfenden JM Nucl Med Biol; 2016 Aug; 43(8):496-505. PubMed ID: 27236285 [TBL] [Abstract][Full Text] [Related]
3. In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences. Dimastromatteo J; Broisat A; Perret P; Ahmadi M; Boturyn D; Dumy P; Fagret D; Riou LM; Ghezzi C J Nucl Med; 2013 Aug; 54(8):1442-9. PubMed ID: 23719858 [TBL] [Abstract][Full Text] [Related]
4. 99mTc-cAbVCAM1-5 imaging is a sensitive and reproducible tool for the detection of inflamed atherosclerotic lesions in mice. Broisat A; Toczek J; Dumas LS; Ahmadi M; Bacot S; Perret P; Slimani L; Barone-Rochette G; Soubies A; Devoogdt N; Lahoutte T; Fagret D; Riou LM; Ghezzi C J Nucl Med; 2014 Oct; 55(10):1678-84. PubMed ID: 25157043 [TBL] [Abstract][Full Text] [Related]
5. Targeted ED-B fibronectin SPECT in vivo imaging in experimental atherosclerosis. Dietrich T; Berndorff D; Heinrich T; Hucko T; Stepina E; Hauff P; Dinkelborg LM; Atrott K; Giovannoni L; Neri D; Fleck E; Graf K; Menssen HD Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):228-37. PubMed ID: 25864530 [TBL] [Abstract][Full Text] [Related]
6. Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions. Broisat A; Hernot S; Toczek J; De Vos J; Riou LM; Martin S; Ahmadi M; Thielens N; Wernery U; Caveliers V; Muyldermans S; Lahoutte T; Fagret D; Ghezzi C; Devoogdt N Circ Res; 2012 Mar; 110(7):927-37. PubMed ID: 22461363 [TBL] [Abstract][Full Text] [Related]
7. Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1. De Vos J; Mathijs I; Xavier C; Massa S; Wernery U; Bouwens L; Lahoutte T; Muyldermans S; Devoogdt N Mol Imaging Biol; 2014 Oct; 16(5):690-8. PubMed ID: 24687730 [TBL] [Abstract][Full Text] [Related]
10. Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque. Ishino S; Mukai T; Kuge Y; Kume N; Ogawa M; Takai N; Kamihashi J; Shiomi M; Minami M; Kita T; Saji H J Nucl Med; 2008 Oct; 49(10):1677-85. PubMed ID: 18794262 [TBL] [Abstract][Full Text] [Related]
11. SPECT/CT Imaging of High-Risk Atherosclerotic Plaques using Integrin-Binding RGD Dimer Peptides. Yoo JS; Lee J; Jung JH; Moon BS; Kim S; Lee BC; Kim SE Sci Rep; 2015 Jun; 5():11752. PubMed ID: 26123253 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive detection of matrix metalloproteinase-9 in atherosclerotic lesions using technetium-99m-labeled single-photon emission computed tomography in vivo. Wang Z; Deng G; Zhang Z; Huang H; Zhao Y Nucl Med Commun; 2017 Apr; 38(4):299-305. PubMed ID: 28234785 [TBL] [Abstract][Full Text] [Related]
14. A Comparison of [ Hu Y; Liu G; Zhang H; Li Y; Gray BD; Pak KY; Choi HS; Cheng D; Shi H Mol Imaging Biol; 2018 Apr; 20(2):249-259. PubMed ID: 28785938 [TBL] [Abstract][Full Text] [Related]
15. Selective Imaging of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Atherosclerotic Lesions in Diabetic and Non-diabetic ApoE Tekabe Y; Johnson LL; Rodriquez K; Li Q; Backer M; Backer JM Mol Imaging Biol; 2018 Feb; 20(1):85-93. PubMed ID: 28421362 [TBL] [Abstract][Full Text] [Related]
16. Single-Chain Variable Fragment Antibody of Vascular Cell Adhesion Molecule 1 as a Molecular Imaging Probe for Colitis Model Rabbit Investigation. Liu C; Zhou J; Cheng X; Xia L; Zhou J; Xu S; Wang Y; Zhang Y; Lu D Contrast Media Mol Imaging; 2019; 2019():2783519. PubMed ID: 30804723 [TBL] [Abstract][Full Text] [Related]
17. Inflammation imaging of atherosclerosis in Apo-E-deficient mice using a (99m)Tc-labeled dual-domain cytokine ligand. Liu Z; Lerman LO; Tang H; Barber C; Wan L; Hui MM; Furenlid LR; Woolfenden JM Nucl Med Biol; 2014; 41(10):785-92. PubMed ID: 25195016 [TBL] [Abstract][Full Text] [Related]
18. Development of 111In-labeled liposomes for vulnerable atherosclerotic plaque imaging. Ogawa M; Umeda IO; Kosugi M; Kawai A; Hamaya Y; Takashima M; Yin H; Kudoh T; Seno M; Magata Y J Nucl Med; 2014 Jan; 55(1):115-20. PubMed ID: 24337605 [TBL] [Abstract][Full Text] [Related]
19. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602 [TBL] [Abstract][Full Text] [Related]
20. Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques? Winkel LC; Groen HC; van Thiel BS; Müller C; van der Steen AF; Wentzel JJ; de Jong M; Van der Heiden K Mol Imaging; 2014; 13():. PubMed ID: 24757762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]